PACB Pacific Biosciences of California
Company Analysis
Latest News
🟢 Pacific Biosciences is trading 5% up today as biotechnology stocks and XBI rise broadly
Pacific Biosciences is trading 5.26% up now at $1.60, extending its recent rebound after an 18.75% gain on August 25, with sector momentum driving broad gains...
🟢 Pacific Biosciences is trading 11% up today amid broad biotechnology-sector strength
Pacific Biosciences is trading 10.94% up now at $1.42 as biotechnology shares strengthen broadly. - No company-specific announcement dated August 25, 2026,...
🟢 Pacific Biosciences is trading 7% up today as XBI gains 2.06%
Pacific Biosciences is trading at $1.37 (+7.03%) as biotech strength, XBI’s 2.06% rise, and a broader risk-on backdrop support the move. - No company-specific...
🔴 Pacific Biosciences is trading 5% down today; catalyst remains unclear
Pacific Biosciences is trading 5.01% down at $1.28, with no new company-specific announcement identified to explain the August 24, 2026 decline. - Recent...
🟢 Pacific Biosciences is trading 10% up today as biotech stocks rally on clinical-news momentum
Pacific Biosciences is trading 10.16% up at $1.35, with the move appearing primarily sector-driven as biotechnology stocks rally alongside positive...
🟢 Pacific Biosciences rises 5.2% — Biotech Sector Continues Upward Trend on Strong Momentum
With Biotech (XBI) up 2.0%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🟢 Pacific Biosciences is trading 13.17% up today after positive Phase 3 melanoma-vaccine results
Pacific Biosciences is trading 13.17% up now at $1.29 after positive Phase 3 melanoma cancer-vaccine results from Moderna and Merck lifted biotechnology-sector...
🟢 Pacific Biosciences is trading 7.94% up today following positive late-stage melanoma cancer-vaccine results
Pacific Biosciences is trading 7.94% up at $1.22 as biotech shares rally following positive late-stage melanoma cancer-vaccine results from Moderna and...
🔴 Pacific Biosciences is trading 5.8% down today amid broader market declines
Pacific Biosciences is trading 5.8% down at $1.14, amid a broader risk-off session with no clear company-specific announcement identified for August 18,...
🟢 Pacific Biosciences is trading 5% up today
Pacific Biosciences is trading higher at $1.21, up 5.21%, though no clear company-specific catalyst has been identified. • PacBio’s latest listed releases...
🟢 Pacific Biosciences is trading 5% up today as softer producer prices lift broader markets
Pacific Biosciences is trading 5.05% up at $1.17, moving alongside stronger broader markets on August 13, 2026, as softer-than-expected producer prices...
🔴 Pacific Biosciences is trading 6.14% down today
Pacific Biosciences is trading 6.14% down now at $1.07, with no fresh company-specific announcement identified for August 12, 2026. - The Nasdaq Composite is...
🔴 Pacific Biosciences is trading 5.29% down today after August 5 revenue miss and guidance cut
Pacific Biosciences is trading at $1.12 (-5.29%), with recent selling pressure following its August 5 earnings report. - The report showed a revenue miss,...
PacBio Drops 10% as Investors Flee Before Earnings — But Can a New CEO and Deeper Cost Cuts Save a Sub-$500M Company?
Shares of Pacific Biosciences tumbled 10.8% to $1.28 as investors rushed to sell ahead of the DNA-sequencing company's Q2 2026 earnings report, scheduled for...
🔴 Pacific Biosciences is trading 10.77% down today after lowered 2026 revenue guidance
Pacific Biosciences is trading 10.77% down now at $1.16 after its August 5, 2026 earnings release showed $39.0 million in second-quarter revenue, below...
Pacific Biosciences' second quarter revenue of $39M misses estimates as the company lowers its full-year outlook.
Pacific Biosciences of California reported second quarter revenue of $39.0 million, a 2% decrease year-over-year, missing analyst estimates of $41.0 million....
🔴 Pacific Biosciences is trading 10.8% down today ahead of Q2 earnings release
Pacific Biosciences is trading 10.8% down at $1.28 as investors de-risk ahead of its Q2 2026 earnings report scheduled for release this afternoon. • Market...
🔴 Pacific Biosciences is trading 5.6% down today ahead of Q2 earnings
Pacific Biosciences is trading 5.6% down today at $1.36 as investors position ahead of its Q2 2026 earnings report scheduled for release this afternoon. • The...
Pacific Biosciences of California Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Analysts expect Pacific Biosciences of California to report Q2 2026 revenue of $41.0 million and a net loss of $0.14 per share, with the stock currently...
🔴 Pacific Biosciences is trading 5.1% down today amid a broader biotech sector pullback
Pacific Biosciences is trading 5.1% down at $1.41 as the broader biotech sector retreats and market risk appetite cools. • The move tracks a roughly 3% drop...